IFP Advisors’s Yarrow Bioscience YARW Stock Holding History

IFP Advisors’s Portfolio YARW Stock Details YARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1	Closed	-$3.96K	–	3262
2021 Q1	$4K	Buy	+1	New	+$7.25K	﹤0.01%	2505
2020 Q4	–	Hold	0	–	–	–	2673
2020 Q3	–	Hold	0	–	–	–	3017
2020 Q2	–	Hold	0	–	–	–	2969

Other funds holding YARW

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HVC

Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return

IFP Advisors's YARW Position: Q2 2021 in Review

IFP Advisors sold out of Yarrow Bioscience (YARW) in Q2 2021, closing a stake of 1 share — an estimated $3.96K sold.

IFP Advisors first reported a position in YARW in Q1 2021 and held it in 1 quarter. The position peaked at $4K in Q1 2021. 63 funds tracked by Wall St. Rank hold YARW as of Q2 2021.

IFP Advisors reported no remaining Yarrow Bioscience position as of Q2 2021 after selling out during the quarter.
IFP Advisors sold 1 Yarrow Bioscience share in Q2 2021, an estimated $3.96K.
IFP Advisors first reported a position in Yarrow Bioscience in Q1 2021 and held it in 1 quarter.
IFP Advisors's Yarrow Bioscience position peaked at $4K in Q1 2021.
63 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q2 2021.

Based on IFP Advisors's 13F filing for Q2 2021, filed 13 Jul 2021.